Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancer Clinical Trial Sponsors Increasingly Favor Non-U.S. Sites, FDA Finds

Executive Summary

The number of clinical trials used for registration of anticancer agents performed at least partially outside the U.S. has increased by approximately 50% in the last five years, FDA reported at the American Society of Clinical Oncology annual meeting
Advertisement

Related Content

AstraZeneca Sets Two NMEs Per Year As Metric Of R&D Success
AstraZeneca Sets Two NMEs Per Year As Metric Of R&D Success
Global Consortium Would Facilitate Early Pediatric Oncology Trials – Cmte.
Pediatric Oncology Subcmte. Should Discuss Timing Of Studies – Workshop
FDA Renewing Push For Consistency In CDER/CBER Oncology Reviews
FDA Renewing Push For Consistency In CDER/CBER Oncology Reviews
Advertisement
UsernamePublicRestriction

Register

PS041951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel